Cencora Q4 Earnings Disappoint, Stock Down 10.1%

Cencora's Q4 earnings show a 5.5% YoY revenue increase to $85.93 billion, missing analysts' expectations by 0.6%. The company's stock is down 10.1% since reporting. Despite strong financial performance, Cencora faces challenges from regulatory scrutiny, inflation, and the potential impact of AI on the industry. The health insurance providers' group reported a slower Q4, with revenues beating estimates by 0.8% and next quarter's guidance in line.